Zhengye Biotechnology Holding Ltd (ZYBT) stock
ZYBTNasdaqPharmaceutical Preparations
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.52+0.09 (+6.29%)
Close on Nov 17, 2026Market cap $72.03MP/E –Yield –
Zhengye Biotechnology EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Zhengye Biotechnology's EV/EBITDA was 7.9× on Feb 27, 2026, against 22.3× a year earlier.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Feb 27, 2026 | 7.9× | −3.6 |
| 2025 | Dec 31, 2025 | 11.5× | – |
See a number that looks wrong?